Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Jul 4;1(1):11-13.
doi: 10.1016/j.jaccao.2019.06.002. eCollection 2019 Sep.

Trastuzumab Cures Cancer and Disrupts the Practice of Cardiology

Richard M Steingart  1 , Anthony F Yu  1 , Chau T Dang  1
Affiliations
Editorial

Trastuzumab Cures Cancer and Disrupts the Practice of Cardiology

Richard M Steingart et al. JACC CardioOncol. .
No abstract available

Keywords: breast cancer; cardiomyopathy; trastuzumab.

PubMed Disclaimer

Figures

None
Graphical abstract
See this image and copyright information in PMC

Comment on

  • doi: 10.1016/j.jaccao.2019.06.004

References

    1. Leong D.P., Cosman T., Alhussein M.M. Safety of continuing trastuzumab despite mild cardiotoxicity: a phase I trial. J Am Coll Cardiol CardioOnc. 2019;1:1–10. - PMC - PubMed
    1. Seidman A., Hudis C., Pierri M.K. Cardiac dysfunction in the trastuzumab clinical trials experience. J Clin Oncol. 2002;20:1215–1221. - PubMed
    1. Tan-Chiu E., Yothers G., Romond E. Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpresing breast cancer: NSABP B-31. J Clin Oncol. 2005;23:7811–7819. - PubMed
    1. HERCEPTIN [trastuzumab] Initial U.S. approval: 1998. Revised 11/2018. [package insert] Genentech; South San Francisco, CA: 2018.
    1. Lynce F., Barac A., Geng X. Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study. Breast Cancer Res Treat. 2019;175:595–603. - PMC - PubMed

Publication types

LinkOut - more resources